Cargando…
Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
BACKGROUND: Both type 1 and type 2 diabetes are well-established risk factors for cardiovascular disease and early mortality. However, few studies have directly compared the hazards of cardiovascular outcomes and premature death among people with type 1 diabetes to those among people with type 2 dia...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858684/ https://www.ncbi.nlm.nih.gov/pubmed/31733656 http://dx.doi.org/10.1186/s12933-019-0953-7 |
_version_ | 1783471003485077504 |
---|---|
author | Lee, You-Bin Han, Kyungdo Kim, Bongsung Lee, Seung-Eun Jun, Ji Eun Ahn, Jiyeon Kim, Gyuri Jin, Sang-Man Kim, Jae Hyeon |
author_facet | Lee, You-Bin Han, Kyungdo Kim, Bongsung Lee, Seung-Eun Jun, Ji Eun Ahn, Jiyeon Kim, Gyuri Jin, Sang-Man Kim, Jae Hyeon |
author_sort | Lee, You-Bin |
collection | PubMed |
description | BACKGROUND: Both type 1 and type 2 diabetes are well-established risk factors for cardiovascular disease and early mortality. However, few studies have directly compared the hazards of cardiovascular outcomes and premature death among people with type 1 diabetes to those among people with type 2 diabetes and subjects without diabetes. Furthermore, information about the hazard of cardiovascular disease and early mortality among Asians with type 1 diabetes is sparse, although the clinical and epidemiological characteristics of Asians with type 1 diabetes are unlike those of Europeans. We estimated the hazard of myocardial infarction (MI), hospitalization for heart failure (HF), atrial fibrillation (AF), and mortality during follow-up in Korean adults with type 1 diabetes compared with those without diabetes and those with type 2 diabetes. METHODS: We used Korean National Health Insurance Service datasets of preventive health check-ups from 2009 to 2016 in this retrospective longitudinal study. The hazard ratios of MI, HF, AF, and mortality during follow-up were analyzed using the Cox regression analyses according to the presence and type of diabetes in ≥ 20-year-old individuals without baseline cardiovascular disease (N = 20,423,051). The presence and type of diabetes was determined based on the presence of type 1 or type 2 diabetes at baseline. RESULTS: During more than 93,300,000 person-years of follow-up, there were 116,649 MIs, 135,532 AF cases, 125,997 hospitalizations for HF, and 344,516 deaths. The fully-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident MI, hospitalized HF, AF, and all-cause death within the mean follow-up of 4.6 years were higher in the type 1 diabetes group than the type 2 diabetes [HR (95% CI) 1.679 (1.490–1.893) for MI; 2.105 (1.901–2.330) for HF; 1.608 (1.411–1.833) for AF; 1.884 (1.762–2.013) for death] and non-diabetes groups [HR (95% CI) 2.411 (2.138–2.718) for MI; 3.024 (2.730–3.350) for HF; 1.748 (1.534–1.993) for AF; 2.874 (2.689–3.073) for death]. CONCLUSIONS: In Korea, the presence of diabetes was associated with a higher hazard of cardiovascular disease and all-cause death. Specifically, people with type 1 diabetes had a higher hazard of cardiovascular disease and all-cause mortality compared to people with type 2 diabetes. |
format | Online Article Text |
id | pubmed-6858684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68586842019-11-29 Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study Lee, You-Bin Han, Kyungdo Kim, Bongsung Lee, Seung-Eun Jun, Ji Eun Ahn, Jiyeon Kim, Gyuri Jin, Sang-Man Kim, Jae Hyeon Cardiovasc Diabetol Original Investigation BACKGROUND: Both type 1 and type 2 diabetes are well-established risk factors for cardiovascular disease and early mortality. However, few studies have directly compared the hazards of cardiovascular outcomes and premature death among people with type 1 diabetes to those among people with type 2 diabetes and subjects without diabetes. Furthermore, information about the hazard of cardiovascular disease and early mortality among Asians with type 1 diabetes is sparse, although the clinical and epidemiological characteristics of Asians with type 1 diabetes are unlike those of Europeans. We estimated the hazard of myocardial infarction (MI), hospitalization for heart failure (HF), atrial fibrillation (AF), and mortality during follow-up in Korean adults with type 1 diabetes compared with those without diabetes and those with type 2 diabetes. METHODS: We used Korean National Health Insurance Service datasets of preventive health check-ups from 2009 to 2016 in this retrospective longitudinal study. The hazard ratios of MI, HF, AF, and mortality during follow-up were analyzed using the Cox regression analyses according to the presence and type of diabetes in ≥ 20-year-old individuals without baseline cardiovascular disease (N = 20,423,051). The presence and type of diabetes was determined based on the presence of type 1 or type 2 diabetes at baseline. RESULTS: During more than 93,300,000 person-years of follow-up, there were 116,649 MIs, 135,532 AF cases, 125,997 hospitalizations for HF, and 344,516 deaths. The fully-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident MI, hospitalized HF, AF, and all-cause death within the mean follow-up of 4.6 years were higher in the type 1 diabetes group than the type 2 diabetes [HR (95% CI) 1.679 (1.490–1.893) for MI; 2.105 (1.901–2.330) for HF; 1.608 (1.411–1.833) for AF; 1.884 (1.762–2.013) for death] and non-diabetes groups [HR (95% CI) 2.411 (2.138–2.718) for MI; 3.024 (2.730–3.350) for HF; 1.748 (1.534–1.993) for AF; 2.874 (2.689–3.073) for death]. CONCLUSIONS: In Korea, the presence of diabetes was associated with a higher hazard of cardiovascular disease and all-cause death. Specifically, people with type 1 diabetes had a higher hazard of cardiovascular disease and all-cause mortality compared to people with type 2 diabetes. BioMed Central 2019-11-16 /pmc/articles/PMC6858684/ /pubmed/31733656 http://dx.doi.org/10.1186/s12933-019-0953-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Lee, You-Bin Han, Kyungdo Kim, Bongsung Lee, Seung-Eun Jun, Ji Eun Ahn, Jiyeon Kim, Gyuri Jin, Sang-Man Kim, Jae Hyeon Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study |
title | Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study |
title_full | Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study |
title_fullStr | Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study |
title_full_unstemmed | Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study |
title_short | Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study |
title_sort | risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858684/ https://www.ncbi.nlm.nih.gov/pubmed/31733656 http://dx.doi.org/10.1186/s12933-019-0953-7 |
work_keys_str_mv | AT leeyoubin riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy AT hankyungdo riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy AT kimbongsung riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy AT leeseungeun riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy AT junjieun riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy AT ahnjiyeon riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy AT kimgyuri riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy AT jinsangman riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy AT kimjaehyeon riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy |